Hong Kong Pharmaceuticals & Biotech Upcoming Dividends

Tong Ren Tang Technologies

Market Cap: HK$4.3b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

Jacobson Pharma

Market Cap: HK$2.1b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.

Pak Fah Yeow International

Market Cap: HK$776.0m

An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.

Jilin Province Huinan Changlong Bio-pharmacy

Market Cap: HK$1.3b

Manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People’s Republic of China.

Sino Biopharmaceutical

Market Cap: HK$84.5b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

JBM (Healthcare)

Market Cap: HK$1.6b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally.

Shandong Xinhua Pharmaceutical

Market Cap: HK$9.5b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

CSPC Pharmaceutical Group

Market Cap: HK$91.5b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

China Resources Pharmaceutical Group

Market Cap: HK$28.3b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.